Abstract
Background: On 7 March 2024, the Chicago Department of Public Health was notified of a positive measles test in a resident of a shelter housing >2100 persons. We estimated the effectiveness of measles-mumps-rubella vaccine (MMR) administered during the outbreak to guide its use as an acute intervention. Methods: We used Pearson χ2 tests to compare unadjusted attack rates (ARs) by age group, number of days exposed, and sex. We estimated adjusted hazard ratios (aHRs) using time-dependent Cox proportional hazards regression models to assess the association between time-varying MMR dose status and the outcome of laboratory-confirmed measles; the final model was adjusted for time-varying exposure to measles virus and age group. We estimated risk-adjusted vaccine effectiveness (VE) as VE = (1 – aHR) × 100. Results: Measles was diagnosed in 52 of 2243 (2.3%) residents who resided in the shelter for ≥1 day during 22 February–4 April 2024. ARs were highest among children aged <6 months (57.1%) and 6–11 months (55.6%) and among residents who were exposed for 8–13 days (10.1%). ARs did not differ by sex. Estimated 1-dose VE was 70% (95% confidence interval [CI], 28%–88%) and estimated ≥2-dose VE was 72% (95% CI, 21%–90%). Conclusions: This study provided a unique opportunity to evaluate MMR VE in a contemporary outbreak setting with a high force of infection and could guide future responses in similar congregate settings. MMR was effective at preventing measles among shelter residents. Public health efforts that prioritize vaccinating persons without ≥2 MMR doses remain critical for limiting transmission.

This publication has 29 references indexed in Scilit: